Delivery Order SPE2DB20D1109-SPE2DB22FP39X
- Not listed
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL pharmaceutical products to the Defense Logistics Agency (DLA). The $1,187.60 fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This delivery order is part of Amerisourcebergen's larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,445.91 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, under the company's Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999 through December 2025. The contract has no set-aside designation and is intended to support medical treatment...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL, a prescription medication, to the Defense Logistics Agency (DLA). The $4,389.87 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor. The contract has an ultimate completion date of October 12, 2023 and was not set aside for any specific program. Amerisourcebergen Drug Corp holds a significant...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml to the Defense Logistics Agency (DLA). The $2,440.77 firm fixed-price delivery order was issued under an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Cencora, Inc., doing business as Amerisourcebergen Drug Corp. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to the Department of Defense and...
- This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $4,803.61 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This federal contract award is for the delivery of LANTUS SOLOSTAR 100 UNIT/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,022.80 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on March 17, 2025, with a completion date of March 18, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml medication to the Defense Logistics Agency (DLA). The $1,706.28 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 13, 2023 and was awarded on September 12, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc.,...
- This contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,187.60 firm-fixed-price delivery order is placed under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with a potential value of up to $999,999,999.00. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/ml 3ml to the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense (DoD). The $5,597.75 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the delivery of Lantus Solostar 100 unit/mL 3mL to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,187.60 and a completion date of June 8, 2023. It is a delivery order under a broader Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999, which serves as a primary vehicle for...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB22FP39XDelivery Order
This federal contract award is for the delivery of Lantus Solostar 100 Unit/ML 3ML pharmaceutical products to the Defense Logistics Agency (DLA). The $1,501.75 firm fixed-price delivery order was issued to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. This contract supports the DLA Troop Support Medical program, which provides medical commodities to military treatment facilities and veterans' healthcare programs. The contract has no set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, serving as a primary vehicle to deliver a wide range of pharmaceutical products and medical supplies to the Department of Defense globally. This delivery order is part of the company's comprehensive support for federal healthcare requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.5k | 6/8/22 |